BMHS plans an expansion, IKN’s prospects still reviewed
02 Oct 2024 16:25
PT Bundamedik Tbk (BMHS), the managing company of Bunda Hospital network, has reaffirmed its expansion plan within the next 3-5 years to untapped locations.
Jinxin Fertility Group takes part in Morula Indonesia, BMHS bags IDR 351.7 billion
26 Aug 2024 13:45
PT Morula Indonesia (MI), a subsidiary of PT Bundamedik Tbk (BMHS) engaged in in-vitro fertilisation (IVF), welcomes its newest shareholder, Jinxin Fertility Group (Jinxin).
Solid operational aspects post-COVID, BMHS saw profit surge of nearly 200%
26 Aug 2024 11:08
As of June 2024, PT Bundamedik Tbk (BMHS) reported slight increase in revenue of 9% year-on-year (yoy) compared to H1 2021.
Profit declined, BMHS saw lowest dividend in the past three years
06 Jun 2024 08:07
PT Bundamedik Tbk (BMHS), the managing company of Rumah Sakit Bunda Hospital network, only distributes cash dividend of IDR 0.56 per share or IDR 4.82 billion for the fiscal year (FY) 2023.
Solid healthcare ecosystem, Bundamedik scored 9.25% profit growth in Q1
03 May 2024 15:21
PT Bundamedik Tbk (BMHS), the managing company of Bundar Hospital network and several diagnostic laboratories, booked net profit of IDR 10.87 billion in the first quarter of 2024.
DGNS schedules rights issue to acquire Asa Ren
18 Apr 2024 10:42
PT Diagnos Laboratorium Utama Tbk (DGNS) will conduct rights issue of a maximum of 921 billion new shares worth IDR 25 per share.
Bundamedik’s net profit took a 91% downturn in 2023
01 Apr 2024 07:58
PT Bundamedik Tbk (BMHS), the managing company of a network of hospitals and other healthcare service providers, only scored net profit of IDR 7.46 billion in 2023.
Diagnos Laboratorium reported its first loss since debut
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.
